Taipei Exchange - Delayed Quote TWD

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)

Compare
112.00
-1.00
(-0.88%)
At close: 1:30:15 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
31,764.00
18,915.00
1,143.00
1,143.00
833.00
Cost of Revenue
13,793.00
7,715.00
77.00
65.00
47.00
Gross Profit
17,971.00
11,200.00
1,066.00
1,078.00
786.00
Operating Expense
166,597.00
144,526.00
261,747.00
121,904.00
118,152.00
Operating Income
-148,626.00
-133,326.00
-260,681.00
-120,826.00
-117,366.00
Net Non Operating Interest Income Expense
49,547.00
34,419.00
3,638.00
1,222.00
4,101.00
Pretax Income
-100,514.00
-101,175.00
-292,133.00
-114,720.00
-99,317.00
Tax Provision
123.00
--
--
15,200.00
--
Net Income Common Stockholders
-93,592.00
-92,037.00
-254,189.00
-121,581.00
-93,072.00
Diluted NI Available to Com Stockholders
-93,592.00
-92,037.00
-254,189.00
-121,581.00
-93,072.00
Basic EPS
-0.80
-0.81
-2.29
-1.11
-0.88
Diluted EPS
-0.80
-0.81
-2.29
-1.11
-0.88
Basic Average Shares
117,429.25
113,269.00
111,134.00
110,862.00
105,713.09
Diluted Average Shares
127,154.00
113,269.00
111,134.00
110,862.00
105,713.09
Total Expenses
180,390.00
152,241.00
261,824.00
121,969.00
118,199.00
Net Income from Continuing & Discontinued Operation
-93,592.00
-92,037.00
-254,189.00
-121,581.00
-93,072.00
Normalized Income
-90,888.00
-92,037.00
-254,189.00
-121,581.00
-93,072.00
Interest Income
53,658.00
41,608.00
6,823.00
2,402.00
4,601.00
Interest Expense
4,111.00
7,189.00
3,185.00
1,180.00
500.00
Net Interest Income
49,547.00
34,419.00
3,638.00
1,222.00
4,101.00
EBIT
-96,403.00
-93,986.00
-288,948.00
-113,540.00
-98,817.00
EBITDA
-84,624.00
-80,659.00
-275,562.00
-100,582.00
-86,284.00
Reconciled Cost of Revenue
13,793.00
7,715.00
77.00
65.00
47.00
Reconciled Depreciation
11,779.00
13,327.00
13,386.00
12,958.00
12,533.00
Net Income from Continuing Operation Net Minority Interest
-93,592.00
-92,037.00
-254,189.00
-121,581.00
-93,072.00
Total Unusual Items Excluding Goodwill
-3,380.00
--
--
--
--
Total Unusual Items
-3,380.00
--
--
--
--
Normalized EBITDA
-81,244.00
-80,659.00
-275,562.00
-100,582.00
-86,284.00
Tax Rate for Calcs
0.00
--
--
0.00
--
Tax Effect of Unusual Items
-676.00
--
--
--
--
12/31/2020 - 2/8/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4194.TWO Holy Stone Healthcare Co., Ltd.
11.40
-0.44%
 
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
 
6875.TWO Pharmosa Biopharm Inc.
52.90
+1.73%
 
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
 
6712.TWO Ever Supreme Bio Technology Co., Ltd
175.50
-0.28%
 
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
 
6550.TW Polaris Group
43.40
+0.46%
 
4168.TWO GlycoNex Incorporation
24.00
0.00%
 
6541.TW Tanvex BioPharma, Inc.
65.30
+3.98%
 
4728.TWO Sunmax Biotechnology Co., Ltd.
275.00
+0.18%